Fresh analysis suggests that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt conventional diet and exercise regimens.
Findings released in a major medical journal shows that while overweight people can lose about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using such treatments should be aware of the danger of fast weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight in about a year and a half.
Weighing Therapies
The study, which reviewed dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Scientists emphasize that individuals who lose weight through lifestyle changes alone usually see a slower creep back—approximately 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists believe the way of the injections accounts for the amplified regain.
These medications copy a natural hormone called GLP-1, which helps regulate hunger.
"Sustained high doses of GLP-1 concentrations far above than normal could lead to the system to produce less of its own natural hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication means hunger is no longer kept in check, making overeating a significant risk."
A Chronic Disease?
Medical guidelines recommend the jabs for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, considering the likelihood of weight regain, the treatment might need to be long-term.
This view is supported by drug manufacturers, who say that the results "highlight the long-term character of excess weight," akin to managing conditions like hypertension.
User Experiences
Individuals who have discontinued the medication explain a intense return of appetite.
"It was like something flipping and I was suddenly starving," described an individual.
This difficulty is worsened if users have not established lasting dietary or behavioural modifications during treatment.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Finally, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits relies on ongoing behavioural management.
